CRISPR Therapeutics AG CRSP

Morningstar Rating
Add To Portfolio
|%
Chart Data Not Available
  • Last Close
  • Sector
  • Industry
  • Investment Style
    Mid Growth
  • Market Cap
  • Forward Div Yield
  • Trailing Div Yield
  • Price/Sales
    21.07
  • Price/Book
    2.24
  • Beta (3-Year)
    -0.99
  • Consensus Forward P/E
  • Trailing 12-mo Rev

Trailing Returns

-34.000.0034.00
Total Return % 1-Day 1-Week 1-Month 3-Month YTD 1-Year 3-Year 5-Year 10-Year 15-Year
CRSP 0.38 0.38 -0.97 -18.90 -32.36 -31.02 -13.86
Industry
Index 0.19 1.07 1.79 -2.03 9.66 5.09 4.86 6.30 6.30 7.74

Related

Morningstar Research
© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy       Disclosures        Accessibility